文献速递慢性肾脏病肾血管病与高血压

冠状动脉血流储备可预测心血管死亡风险,且不受CKD分期影响

Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.
PubMed 文献 · Kidney Int · 2017-10-13

本研究在单中心通过心肌灌注正电子发射断层扫描定量绝对心肌血流量和冠状动脉血流储备(CFR),按eGFR将个体分为标准CKD分期,分析CFR与CKD分期及心血管死亡的关系。结果显示CFR与CKD分期显著相关,早期CKD即下降,但4期、5期和透析依赖CKD间无显著差异;校正心血管危险因素后,CFR与心血管死亡显著相关(每三分位HR 0.76,95%CI 0.63-0.92),且无CKD效应修饰证据。

要点

  • CFR在早期CKD即显著下降,但4期、5期及透析依赖CKD间无显著差异。
  • CFR与心血管死亡显著相关(每三分位HR 0.76,95%CI 0.63-0.92),不受CKD分期影响。
  • 提示CKD本身而非透析是微血管疾病的主要驱动因素。

核心结论

  • 冠状动脉血流储备与心血管死亡风险显著相关,且不受CKD严重程度影响。
  • CFR在早期CKD即降低,但在5期或透析依赖CKD中无进一步下降,提示CKD生理而非透析是微血管疾病的主要驱动因素。

研究设计与样本

  • 单中心研究,通过心肌灌注正电子发射断层扫描定量绝对心肌血流量和冠状动脉血流储备。
  • 按估算肾小球滤过率将个体分为标准CKD分期,分析CFR与CKD分期及心血管死亡的关系,模型校正心血管危险因素。

主要发现

  • CFR与CKD分期显著相关,早期CKD即下降,但4期、5期和透析依赖CKD间无显著差异。
  • 肾功能保留者CFR为2.01,CKD 1期为2.06,2期为1.91,3期为1.68,4期为1.54,5期为1.66,透析依赖CKD为1.55。
  • 校正模型中CFR与心血管死亡显著相关(每三分位HR 0.76,95%CI 0.63-0.92),无CKD效应修饰证据。

临床怎么用

  • CFR可作为CKD患者心血管死亡风险的预测指标,不受CKD分期限制。
  • 早期CKD即应关注微血管功能障碍对心血管风险的影响。

局限性

  • 单中心研究,数据来自单一机构,外推性需进一步验证。
  • 原文未报告样本量、P值等详细统计信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Microvascular rarefaction is found in experimental uremia, but data from patients with chronic kidney disease (CKD) are limited. We therefore quantified absolute myocardial blood flow and coronary flow reserve (the ratio of peak to resting flow) from myocardial perfusion positron emission tomography scans at a single institution. Individuals were classified into standard CKD categories based on the estimated glomerular filtration rate. Associations of coronary flow reserve with CKD stage and cardiovascular mortality were analyzed in models adjusted for cardiovascular risk factors. The coronary flow reserve was significantly associated with CKD stage, declining in early CKD, but it did not differ significantly among individuals with stage 4, 5, and dialysis-dependent CKD. Flow reserve with preserved kidney function was 2.01, 2.06 in stage 1 CKD, 1.91 in stage 2, 1.68 in stage 3, 1.54 in stage 4, 1.66 in stage 5, and 1.55 in dialysis-dependent CKD. Coronary flow reserve was significantly associated with cardiovascular mortality in adjusted models (hazard ratio 0.76, 95% confidence interval: 0.63-0.92 per tertile of coronary flow reserve) without evidence of effect modification by CKD. Thus, coronary flow reserve is strongly associated with cardiovascular risk regardless of CKD severity and is low in early stage CKD without further decrement in stage 5 or dialysis-dependent CKD. This suggests that CKD physiology rather than the effects of dialysis is the primary driver of microvascular disease. Our findings highlight the potential contribution of microvascular dysfunction to cardiovascular risk in CKD and the need to define mechanisms linking low coronary flow reserve to mortality.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Charytan DM, Skali H, Shah NR, et al. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int. 2017. PMID: 29032954. doi:10.1016/j.kint.2017.07.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。